Medicine Article Rewrite: Methylphenidate Controlled-Release Tablets
Generic Name and Brand Names
The generic name for this medication is methylphenidate controlled-release tablets, also known as meth-il-FEN-i-date. It is available under the brand names Methylin ER and Ritalin SR.
Methylphenidate controlled-release tablets belong to the class of drugs known as CNS stimulants.
This article was medically reviewed by XanaxBars.Green and was last updated on March 2, 2023.
It is important to note that this medication has a risk of abuse and misuse. It should only be used as directed by a doctor. Patients should inform their doctor if they have a history of drug or alcohol abuse or addiction.
Methylphenidate controlled-release tablets are primarily used to treat attention deficit problems with hyperactivity and narcolepsy. However, it may also be prescribed for other reasons. Patients should discuss their specific needs with their doctor.
Prior to taking methylphenidate controlled-release tablets, patients should inform their doctor if they have an allergy to methylphenidate or any other part of the medication. Additionally, patients with certain health problems, such as glaucoma, agitation, anxiety, overactive thyroid, blood vessel disease, high blood pressure, heart structure problems or other heart problems, Tourette’s syndrome or tics, or a history of stroke should also inform their doctor before taking this medication.
Patients should inform their doctor and pharmacist about all medications, including prescription and over-the-counter drugs, natural products, and vitamins, that they are taking. This is important to ensure that it is safe to take methylphenidate controlled-release tablets with all other drugs and health problems. Patients should not start, stop, or change the dose of any drug without consulting their doctor.
Instructions for Use
Patients should take methylphenidate controlled-release tablets as directed by their doctor. It is typically taken in the morning and may need to be taken with food. Patients should swallow the tablet whole and not chew, break, or crush it. If the medication stops working well, patients should contact their doctor before increasing the dosage.
As with all medications, there is a risk of side effects when taking methylphenidate controlled-release tablets. Patients should contact their doctor immediately if they experience any severe side effects, such as signs of an allergic reaction, high blood pressure, liver problems, joint pain, seizures, shakiness, trouble controlling body movements, sweating, restlessness, change in color of hands or feet, numbness or pain in the hands or feet, sores or wounds on the fingers or toes, muscle pain or weakness, change in sex interest, painful erection lasting longer than four hours, new or worse behavior and mood changes, or any other concerning symptoms.
Storage and Disposal
Methylphenidate controlled-release tablets should be stored at room temperature in a dry place and protected from light. Patients should keep all medications out of reach of children and pets and dispose of any unused or expired medication properly.
If symptoms do not improve or worsen, patients should contact their doctor. Patients should not share their medication with others or take anyone else’s medication. Patients should read the medication guide carefully and consult their doctor or pharmacist with any questions or concerns.
Frequently Asked Questions
For more information about methylphenidate controlled-release tablets, patients should consult their healthcare provider.
This article is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their doctor or healthcare provider with any questions or concerns they may have regarding their health or medication.